A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer
A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer
Recruiting · NCT06623136 · Registry updated 2025-09-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-09-26 | NCT06623136 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elpiscience (Suzhou) Biopharma, Ltd. | 4 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Chest Hospital, Capital Medical University | Beijing | China | 6 |
| Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute, Shandong Cancer Hospital) | Jinan | China | 1 |
| Henan Cancer Hospital | Zhengzhou | China | 98 |
| Jilin Cancer Hospital | Changchun | China | 24 |
| Shanxi Provincial Cancer Hospital | Taiyuan | China | 16 |
| Taizhou Hospital | Taizhou | China | 1 |
| The First Affiliated Hospital of He'nan University of Science and Technology | Luoyang | China | 1 |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | 77 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 103 |